Laura Zanotti

Brescia, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 69 publications

Decoding BRCA1 and BRCA2 Mutations in High-Grade Serous Ovarian Cancer: Impact of Location and Type of Mutation on Prognosis and PARP Inhibitor Treatment.

Decoding BRCA1 and BRCA2 Mutations in High-Grade Serous Ovarian Cancer: Impact of Location and Type of Mutation on Prognosis and PARP Inhibitor Treatment.

Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society

Published: November 27, 2025

Clinical Significance of Soluble L1CAM Serum Levels in Patients with High-Risk Endometrial Cancer.

Clinical Significance of Soluble L1CAM Serum Levels in Patients with High-Risk Endometrial Cancer.

Journal: Biomedicines

Published: September 08, 2025

Serum miRNA-based diagnostic models for endometriosis: from discovery to validation.

Serum miRNA-based diagnostic models for endometriosis: from discovery to validation.

Journal: Human reproduction (Oxford, England)

Published: May 22, 2025

Circulating Serum Micro-RNA as Non-Invasive Diagnostic Biomarkers of Endometriosis.

Circulating Serum Micro-RNA as Non-Invasive Diagnostic Biomarkers of Endometriosis.

Journal: Biomedicines

Published: October 03, 2024

Optimizing the first-line treatment for metastatic colorectal cancer.

Optimizing the first-line treatment for metastatic colorectal cancer.

Journal: Frontiers in oncology

Published: June 24, 2023

Integrated Biomarker Analysis Reveals L1CAM as a Potential Stratification Marker for No Specific Molecular Profile High-Risk Endometrial Carcinoma.

Integrated Biomarker Analysis Reveals L1CAM as a Potential Stratification Marker for No Specific Molecular Profile High-Risk Endometrial Carcinoma.

Journal: Cancers

Published: June 29, 2022

VEGF-D Serum Level as a Potential Predictor of Lymph Node Metastasis and Prognosis in Vulvar Squamous Cell Carcinoma Patients.

VEGF-D Serum Level as a Potential Predictor of Lymph Node Metastasis and Prognosis in Vulvar Squamous Cell Carcinoma Patients.

Journal: Frontiers in oncology

Published: November 19, 2021

L1CAM expression as a predictor of platinum response in high-risk endometrial carcinoma.

L1CAM expression as a predictor of platinum response in high-risk endometrial carcinoma.

Journal: International journal of cancer

Published: November 10, 2021

Integrated mutational landscape analysis of uterine leiomyosarcomas.

Integrated mutational landscape analysis of uterine leiomyosarcomas.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: April 20, 2021

Comprehensive Profiling of Hypoxia-Related miRNAs Identifies miR-23a-3p Overexpression as a Marker of Platinum Resistance and Poor Prognosis in High-Grade Serous Ovarian Cancer.

Comprehensive Profiling of Hypoxia-Related miRNAs Identifies miR-23a-3p Overexpression as a Marker of Platinum Resistance and Poor Prognosis in High-Grade Serous Ovarian Cancer.

Journal: Cancers

Published: April 15, 2021

Infiltration by CXCL10 Secreting Macrophages Is Associated With Antitumor Immunity and Response to Therapy in Ovarian Cancer Subtypes.

Infiltration by CXCL10 Secreting Macrophages Is Associated With Antitumor Immunity and Response to Therapy in Ovarian Cancer Subtypes.

Journal: Frontiers in immunology

Published: April 02, 2021

Chemotherapy-induced neurotoxicity in the treatment of gynecological cancers: State of art and an innovative approach for prevention.

Chemotherapy-induced neurotoxicity in the treatment of gynecological cancers: State of art and an innovative approach for prevention.

Journal: World journal of clinical oncology

Published: February 26, 2021

Showing 1-12 of 69

Last Updated: 09/26/2026